{
}
UBS has maintained a Buy rating for Sarepta Therapeutics with a price target of $188, despite a recent patient death linked to its gene therapy Elevidys, which has caused the stock to drop over 26%. Analyst Eliana Merle views the market reaction as exaggerated and emphasizes the ongoing demand for Elevidys, the only approved treatment for Duchenne muscular dystrophy. While some analysts express caution regarding safety and sales forecasts, others remain optimistic about the drug's potential and future revenue growth.
Sarepta Therapeutics' shares saw volatility following a patient's death linked to its gene therapy, Elevidys, yet UBS analyst Eliana Merle maintained a Buy rating with a target of USD 188, viewing the market's reaction as an overreaction. Despite the incident, demand for Elevidys remains strong, and revenue growth is robust at 53% year-over-year. Analysts' responses vary, with some expressing caution while others uphold positive outlooks for the company's future performance.
Arrowhead Pharmaceuticals, Inc.
Companies
| Symbol | ARWR |
| Name | Arrowhead Pharmaceuticals, Inc. |
| Currency | USD |
| Sector | Health Care |
| IndustryGroup | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Market | NASDAQ Global Select |
| Country | United States |
| State | CA |
| City | Pasadena |
| Zipcode | 91105 |
| Website | http://arrowheadpharma.com |
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
analysts divided on sarepta therapeutics after patient death linked to elevidys
United States Dollar
JPMorgan U.S. Research Enhanced Large Cap ETF
Leerink Partners LLC
Arrowhead Pharmaceuticals, Inc.
REGENXBIO Inc.
Cantor Fitzgerald Equity Opp A
H.C. Wainwright & Co. LLC
Sarepta Therapeutics, Inc.
USA
Eliana Merle
Show more
16:08 19.03.2025
analysts divided on sarepta therapeutics after patient death linked to elevidys
United States Dollar
JPMorgan U.S. Research Enhanced Large Cap ETF
Leerink Partners LLC
Arrowhead Pharmaceuticals, Inc.
REGENXBIO Inc.
Cantor Fitzgerald Equity Opp A
H.C. Wainwright & Co. LLC
Sarepta Therapeutics, Inc.
USA
Eliana Merle
Show more
16:08 19.03.2025
Trending
Subcategory
Industry Trends
Corporate News
Startups & Entrepreneurship
Global Trade Developments
Government Economic Policies
Retail and Consumer Goods
Supply Chain Management
Industry Mergers & Acquisitions
Stock Market Updates
Energy Sector Developments
Venture Capital Investments
Global Financial Events
Finance Mergers & Acquisitions
Central Bank Actions
Cryptocurrency & Blockchain Regulations
Emerging Startups
Funding Rounds & Investments
Inflation and Monetary Impact
Private Equity Deals
Market Analysis and Predictions
Countries:
Companies:
Apple Inc.
NVIDIA Corporation
Google Inc.
Dell Technologies Inc.
Samsung Securities Co.,Ltd.
Learning Resources Inc.
MGA Entertainment Inc.
XPeng Inc.
Toyota Motor Corp
State Street Global Advisors Luxembourg SICAV - SSGA EMU ESG Screened Equity Fund
European Union Bonds
Taiwan Semiconductor Manufacturing Company Limited
Microsoft Corporation
Verizon Communications Inc.
OpenAI ERC USD
SLB 4,6% 01JUN25
Equinor Ventures AS
Quanta Services, Inc.
Gold Circuit Electronics Ltd.
Unimicron Technology Corp.
Currencies:
United States Dollar
Indian Rupee
Chinese Yuan
Euro
Japanese Yen
Australian Dollar
United Arab Emirates Dirham
British Pound Sterling
New Taiwan Dollar
New Zealand Dollar
Vietnamese Đồng
South Korean Won
Egyptian Pound
Thai Baht
Saudi Riyal
Indonesian Rupiah
South African Rand
Malaysian Ringgit
Singapore Dollar
Lebanese Pound
People: